Small RNA-mediated transcriptional modulation

RNA Nanotechnology

Volumn , Issue , 2014, Pages 245-286

  Roberts, Thomas C ^a   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOTECHNOLOGY;

SMALL RNA; TRANSCRIPTIONAL MODULATION;

NANOSTRUCTURED MATERIALS;

EID: 84974559940     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814411653     Document Type: Chapter

References (140)

1. Filipowicz, W. (2005). RNAi: the nuts and bolts of the RISC machine. Cell, 122, 17-20.
2. Meister, G., et al. (2004). Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 15, 185-197.
3. Dykxhoorn, D.M., Novina, C.D., and Sharp, P.A. (2003). Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol., 4, 457-467.
4. Capodici, J., Karikó, K., and Weissman, D. (2002). Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol., 169, 5196-5201.
5. Creamer, K.M., and Partridge, J.F. (2011). RITS-connecting transcription, RNA interference, and heterochromatin assembly in fission yeast. Wiley Interdiscip. Rev. RNA, 2, 632-646.
6. Verdel, A., Vavasseur, A., Le Gorrec,M., and Touat-Todeschini, L. (2009). Common themes in siRNA-mediated epigenetic silencing pathways. Int. J. Dev. Biol., 53, 245-257.
7. Grewal, S.I.S., and Elgin, S.C.R. (2007). Transcription and RNA interference in the formation of heterochromatin. Nature, 447, 399-406.
8. Matzke, M.A., Matzke, A.J., Pruss, G.J., and Vance, V.B. (2001). RNAbased silencing strategies in plants. Curr. Opin. Genet. Dev., 11, 221-227.
9. Egger, G., Liang, G., Aparicio, A., and Jones, P.A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
10. Strahl, B.D., and Allis, C.D. (2000). The language of covalent histone modifications. Nature, 403, 41-45.
11. Jenuwein, T., and Allis, C.D. (2001). Translating the histone code. Science, 293, 1074-1080.
12. Lehnertz, B., et al. (2003). Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol., 13, 1192-1200.
13. Viré, E., et al. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature, 439, 871-874.
14. Paro, R. (1995). Propagating memory of transcriptional states. Trends Genet., 11, 295-297.
15. Morris, K.V., Chan, S.W.-L., Jacobsen, S.E., and Looney, D.J. (2004). Small interfering RNA-induced transcriptional gene silencing in human cells. Science, 305, 1289-1292.
16. Weinberg, M.S., et al. (2006). The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA, 12, 256-262.
17. Hawkins, P.G., et al. (2009). Promoter targeted small RNAs induce longterm transcriptional gene silencing in human cells. Nucleic Acids Res., 37, 2984-2995.
18. Suzuki, K., et al. (2005). Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J. RNAi Gene Silencing, 1, 66-78.
19. Yamagishi, M., et al. (2009). Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect., 11, 500-508.
20. Kim, J.-W., et al. (2007). Short hairpin RNA causes the methylation of transforming growth factor-beta receptor II promoter and silencing of the target gene in rat hepatic stellate cells. Biochem. Biophys. Res. Commun., 359, 292-297.
21. Pulukuri, S.M.K., and Rao, J.S. (2007). Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis. Cancer Res., 67, 6637-6646.
22. Turner, A.-M.W., De La Cruz, J., and Morris, K.V. (2009). Mobilizationcompetent lentiviral vector-mediated sustained transcriptional modulation of HIV-1 expression. Mol. Ther., 17, 360-368.
23. Ting, A.H., Schuebel, K.E., Herman, J.G., and Baylin, S.B. (2005). Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet., 37, 906-910.
24. Liu, J., et al. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305, 1437-1441.
25. Lippman, Z., et al. (2003). Distinct mechanisms determine transposon inheritance and methylation via small interfering RNA and histone modification. PLoS Biol., 1, E67.
26. Verdel, A., et al. (2004). RNAi-mediated targeting of heterochromatin by the RITS complex. Science, 303, 672-676.
27. Kim, D.H., Villeneuve, L.M., Morris, K.V., and Rossi, J.J. (2006). Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol., 13, 793-797.
28. Rivas, F.V., et al. (2005). Purified Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol. Biol., 12, 340-349.
29. Tolia, N.H., and Joshua-Tor, L. (2007). Slicer and the argonautes. Nat. Chem. Biol., 3, 36-43.
30. Suzuki, K., et al. (2008). Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J. Biol. Chem., 283, 23353-23363.
31. Fuks, F., et al. (2001). Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J., 20, 2536-2544.
32. Datta, J., et al. (2003). Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. J. Cell. Biochem., 88, 855-864.
33. Fuks, F., Hurd, P.J., Deplus, R., and Kouzarides, T. (2003). The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res., 31, 2305-2312.
34. Viré, E., et al. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature, 439, 871-874.
35. Jeffery, L., and Nakielny, S. (2004). Components of the DNAmethylation system of chromatin control are RNA-binding proteins. J. Biol. Chem., 279, 49479-49487.
36. Castanotto, D., et al. (2005). Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter inHeLa cells. Mol Ther., 12, 179-183.
37. Mehndiratta, M., et al. (2011). CpG Hypermethylation of the C-myc promoter by dsRNA results in growth suppression. Mol. Pharm., 8, 2302-2309.
38. Clark, M.B., et al. (2011). The reality of pervasive transcription. PLoS Biol., 9, e1000625; discussion e1001102.
39. Kapranov, P., et al. (2005). Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res., 15, 987-997.
40. Dahary, D., Elroy-Stein, O., and Sorek, R. (2005). Naturally occurring antisense: transcriptional leakage or real overlap? Genome Res., 15, 364-368.
41. Lapidot, M., and Pilpel, Y. (2006). Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep., 7, 1216-1222.
42. Katayama, S., et al. (2005). Antisense transcription in the mammalian transcriptome. Science, 309, 1564-1566.
43. Seila, A.C., Core, L.J., Lis, J.T., and Sharp, P.A. (2009). Divergent transcription: a new feature of active promoters. Cell Cycle, 8, 2557-2564.
44. Kapranov, P., et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316, 1484-1488.
45. Preker, P., et al. (2008). RNA exosome depletion reveals transcription upstream of active human promoters. Science, 322, 1851-1854.
46. Han, J., Kim, D., and Morris, K.V. (2007). Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl. Acad. Sci. U S A, 104, 12422-12427.
47. Schmitz, K.-M., Mayer, C., Postepska, A., and Grummt, I. (2010). Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev., 24, 2264-2269.
48. Martianov, I., et al. (2007). Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature, 445, 666-670.
49. Sun, B.K., Deaton, A.M., and Lee, J.T. (2006). A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol. Cell, 21, 617-628.
50. Klase, Z., et al. (2007). HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol. Biol., 8, 63.
51. Lim, H.G.W., Suzuki, K., Cooper, D.A., and Kelleher, A.D. (2008). Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro. Mol. Ther., 16, 565-570.
52. Turunen, M.P., et al. (2009). Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism:a novel example of epigenetherapy. Circ. Res., 105, 604-609.
53. Perrone, L., et al. (2010). Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death Dis., 1, e65.
54. Zhou, J., et al. (2011). Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Gynecol. Oncol., 124, 296-302.
55. Hong, D., et al. (2009). Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells. Br. J. Cancer, 101, 1798-1804.
56. Palanichamy, J.K., et al. (2010). Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization. Mol. Cancer Ther., 9, 2114-2122.
57. Murayama, A., et al. (2006). A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J., 25, 1081-1092.
58. Zhang, M.-X., et al. (2005). Regulation of endothelial nitric oxide synthase by small RNA. Proc. Natl. Acad. Sci. U S A, 102, 16967-16972.
59. Bühler, M., Mohn, F., Stalder, L., and Mühlemann, O. (2005). Transcriptional silencing of nonsense codon-containing immunoglobulin minigenes. Mol. Cell, 18, 307-317.
60. Gonzalez, S., Pisano, D.G., and Serrano, M. (2008). Mechanistic principles of chromatin remodeling guided by siRNAs andmiRNAs. Cell Cycle, 7, 2601-2608.
61. Gonzalez, S., et al. (2006). Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature, 440, 702-706.
62. Wang, X., et al. (2007). The proximal GC-rich region of p16(INK4a) gene promoter plays a role in its transcriptional regulation. Mol. Cell. Biochem., 301, 259-266.
63. Feng, X.-Z., et al. (2008). Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro. World J. Gastroenterol., 14, 3006-3014.
64. Taft, R.J., Hawkins, P.G., Mattick, J.S., and Morris, K.V. (2011). The relationship between transcription initiation RNAs and CCCTC-binding factor (CTCF) localization. Epigenet. Chromatin, 4, 13.
65. Younger, S.T., and Corey, D.R. (2011). Transcriptional regulation by miRNAmimics that target sequences downstream of gene termini. Mol. Biosyst., 7, 2383-2388.
66. Alló, M., et al. (2009). Control of alternative splicing through siRNAmediated transcriptional gene silencing. Nat. Struct. Mol. Biol., 16, 717-724.
67. Kim, D.H., Saetrom, P., Snøve, O., and Rossi, J.J. (2008). MicroRNAdirected transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U S A, 105, 16230-16235.
68. Tan, Y., et al. (2009). Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol. Biol., 10, 12.
69. Benhamed, M., et al. (2012). Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol., 14, 266-275.
70. Dean, A. (2011). In the loop: long range chromatin interactions and gene regulation. Brief Funct. Genomics, 10, 3-10.
71. Yue, X., et al. (2010). Transcriptional regulation by small RNAs at sequences downstream from 3_ gene termini. Nat. Chem. Biol., 6, 621-629.
72. Holstege, F.C., Fiedler, U., and Timmers, H.T. (1997). Three transitions in the RNA polymerase II transcription complex during initiation. EMBO J., 16, 7468-7480.
73. Milne, L., Xu, Y., Perrin, D.M., and Sigman, D.S. (2000). An approach to gene-specific transcription inhibition using oligonucleotides complementary to the template strand of the open complex. Proc. Natl. Acad. Sci. U S A, 97, 3136-3141.
74. Janowski, B.A., et al. (2005). Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol., 1, 216-222.
75. Janowski, B.A., et al. (2005). Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol., 1, 216-222.
76. Janowski, B.A., et al. (2006). Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat. Struct. Mol. Biol., 13, 787-792.
77. Janowski, B.A., et al. (2005). Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol., 1, 216-222.
78. Janowski, B.A., et al. (2005). Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat. Chem. Biol., 1, 210-215.
79. Beane, R.L., et al. (2007). Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA. Biochemistry, 46, 7572-7580.
80. Beane, R., et al. (2008). Recognition of chromosomal DNA inside cells by locked nucleic acids. Biochemistry, 47, 13147-13149.
81. Watts, J.K., et al. (2010). Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters. Nucleic Acids Res., 38, 5242-5259.
82. Napoli, S., et al. (2009). Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J., 28, 1708-1719.
83. Schwartz, J.C., et al. (2008). Antisense transcripts are targets for activating small RNAs. Nat. Struct. Mol. Biol., 15, 842-848.
84. Janowski, B.A., et al. (2005). Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat. Chem. Biol., 1, 210-215.
85. Chu, Y., et al. (2010). Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res., 38, 7736-7748.
86. Jiang, G., et al. (2012). Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells. PLoS ONE, 7, e31379.
87. Li, L.-C., et al. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. U S A, 103, 17337-17342.
88. Morris, K.V., et al. (2008). Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet., 4, e1000258.
89. Modarresi, F., et al. (2012). Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat. Biotechnol., 30(5), 453-459.
90. Mao, Q., et al. (2008). Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem. Biophys. Res. Commun., 375, 566-570.
91. Huang, V., et al. (2010). RNAa is conserved in mammalian cells. PLoS ONE, 5, e8848.
92. Junxia, W., et al. (2010). Double strand RNA-guided endogeneous Ecadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. Cancer Sci., 101, 1790-1796.
93. Janowski, B.A., et al. (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol., 3, 166-173.
94. Matsui, M., et al. (2010). Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem. Biol., 17, 1344-1355.
95. Chen, R., et al. (2011). Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J. Sex Med., 8, 2773-2780.
96. Matilainen, J.M., et al. (2010). Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta, 1803, 1276-1286.
97. Majid, S., et al. (2010). MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer, 116, 5637-5649.
98. Place, R.F., et al. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U S A, 105, 1608-1613.
99. Hawkins, P.G., and Morris, K.V. (2010). Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription, 1, 165-175.
100. Huang, V., et al. (2012). Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res., 40, 1695-1707.
101. Wang, J., et al. (2010). Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res., 70, 10182-10191.
102. Wang, X., et al. (2012). Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem. J., 443, 821-828.
103. Qin, Q., et al. (2012). RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells.World J. Surg. Oncol., 10, 11.
104. Panning, B., and Jaenisch, R. (1998). RNA and the epigenetic regulation of X chromosome inactivation. Cell, 93, 305-308.
105. Rougeulle, C., and Heard, E. (2002). Antisense RNA in imprinting:spreading silence through air. Trends Genet., 18, 434-437.
106. Qureshi, I.A., Mattick, J.S., and Mehler, M.F. (2010). Long non-coding RNAs in nervous systemfunction and disease. Brain Res., 1338, 20-35.
107. Guttman, M., et al. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature, 477, 295-300.
108. Huarte, M., et al. (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142, 409-419.
109. Wang, K.C., and Chang, H.Y. (2011). Molecular mechanisms of long noncoding RNAs. Mol. Cell, 43, 904-914.
110. Yu, W., et al. (2008). Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 451, 202-206.
111. Tufarelli, C., et al. (2003). Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet., 34, 157-165.
112. Turner, A.-M.W., and Morris, K.V. (2010). Controlling transcription with noncoding RNAs in mammalian cells. BioTechniques, 48, ix-xvi.
113. Janowski, B.A., Hu, J., and Corey, D.R. (2006). Silencing gene expression by targeting chromosomal DNA with antigene peptide nucleic acids and duplex RNAs. Nat. Prot., 1, 436-443.
114. Reynolds, A., et al. (2004). Rational siRNA design for RNA interference. Nat. Biotechnol., 22, 326-330.
115. Sherman, M.P., and Greene,W.C. (2002). Slipping through the door: HIV entry into the nucleus. Microbes Infect., 4, 67-73.
116. Morris, K.V. (2005). siRNA-mediated transcriptional gene silencing:the potential mechanism and a possible role in the histone code. Cell. Mol. Life Sci., 62, 3057-3066.
117. Hwang, H.-W.,Wentzel, E.A., and Mendell, J.T. (2007). A hexanucleotide element directs microRNA nuclear import. Science, 315, 97-100.
118. Liao, J.-Y., et al. (2010). Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3_ trailers. PLoS ONE, 5, e10563.
119. Braasch, D.A., et al. (2003). RNA interference in mammalian cells by chemically-modified RNA. Biochemistry, 42, 7967-7975.
120. Moreno, P.M.D., et al. (2009). A synthetic snRNA m3G-CAP enhances nuclear delivery of exogenous proteins and nucleic acids. Nucleic Acids Res., 37, 1925-1935.
121. Jackson, A.L., et al. (2006). Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA, 12, 1179-1187.
122. Bridge, A.J., et al. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet., 34, 263-264.
123. Sledz, C.A., et al. (2003). Activation of the interferon system by shortinterfering RNAs. Nat. Cell Biol., 5, 834-839.
124. Elbashir, S.M., et al. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
125. Hornung, V., et al. (2005). Sequence-specific potent induction of IFNalpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med., 11, 263-270.
126. Judge, A.D., et al. (2005). Sequence-dependent stimulation of themammalian innate immune response by synthetic siRNA. Nat. Biotechnol., 23, 457-462.
127. Kim, D.-H., et al. (2004). Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol., 22, 321-325.
128. Weinberg, M.S., et al. (2007). An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation. Nucleic Acids Res., 35, 7303-7312.
129. Moses, J., Goodchild, A., and Rivory, L.P. (2010). Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targeting. RNA, 16, 430-441.
130. Suzuki, K., et al. (2011). Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific. RNA Biol., 8, 1035-1046.
131. Das, A.T., et al. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol., 78, 2601-2605.
132. Boden, D., et al. (2003). Human immunodeficiency virus type 1 escape from RNA interference. J. Virol., 77, 11531-11535.
133. Westerhout, E.M., et al. (2005). HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res., 33, 796-804.
134. von Eije, K.J., ter Brake, O., and Berkhout, B. (2008). Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol., 82, 2895-2903.
135. Li, M.-J., et al. (2005). Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolarlocalizing TAR decoy. Mol. Ther., 12, 900-909.
136. Aguilar-Cordova, E., et al. (1994). A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses, 10, 295-301.
137. Wu, X., and Pandolfi, P.P. (2001). Mouse models for multistep tumorigenesis. Trends Cell Biol., 11, S2-S9.
138. Pulukuri, S.M.K., Estes, N., Patel, J., and Rao, J.S. (2007). Demethylationlinked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res., 67, 930-939.
139. Ylä-Herttuala, S., and Alitalo, K. (2003). Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med., 9, 694-701.
140. Grimm D, et al. (2009). Fatality inmice due to oversaturation of cellular microRNA. Nature, 441, 537-41.